Global Propranolol Market Size, Share, Trends and Forecast 2022-2030

Description

Propranolol, sold under the brand name Inderal among others, is a medication of the beta blocker class. It is used to treat high blood pressure, a number of types of irregular heart rate, thyrotoxicosis, capillary hemangiomas, performance anxiety, and essential tremors. It is used to prevent migraine headaches, and to prevent further heart problems in those with angina or previous heart attacks. It can be taken by mouth or by injection into a vein.
Industry Insights

Due to the COVID-19 pandemic, the global Propranolol market size is estimated to be worth US$ 386 million in 2021 and is forecast to a readjusted size of US$ 477.8 million by 2028 with a CAGR of 3.1% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Propranolol market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Propranolol landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Global Propranolol key players include Apotex, Teva, Atnas Pharma, AstraZeneca, Mylan, etc. Global top five manufacturers hold a share over 28%.

Europe is the largest market, with a share about 30%, followed by North America, and Asia-Pacific, both have a share about 44 percent.

In terms of product, Oral is the largest segment, with a share over 98%. And in terms of application, the largest application is Arrhythmia, followed by Hypertension, and Others.

This report focuses on Propranolol volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Propranolol market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, South America, Japan and India, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Propranolol market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Oral

Injection

Segment by Application

Arrhythmia

Hypertension

Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Apotex

Teva

Atnas Pharma

AstraZeneca

Mylan

Novartis

Sanofi

Yabang Pharma

Sawai Seiyaku

ABZ-Pharma

Towa Yakuhin

Zydus Pharma

Nichi-Iko Pharmaceutical

Intas Pharma

IFET

Iqfarma

Zentiva

TABLE OF CONTENT

1 Propranolol Market Overview
1.1 Product Overview and Scope of Propranolol

1.2 Propranolol Segment by Type

1.2.1 Global Propranolol Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Oral

1.2.3 Injection

1.3 Propranolol Segment by Application

1.3.1 Global Propranolol Sales Comparison by Application: (2022-2028)

1.3.2 Arrhythmia

1.3.3 Hypertension

1.3.4 Others

1.4 Global Propranolol Market Size Estimates and Forecasts

1.4.1 Global Propranolol Revenue 2017-2028

1.4.2 Global Propranolol Sales 2017-2028

1.4.3 Propranolol Market Size by Region: 2017 Versus 2021 Versus 2028

2 Propranolol Market Competition by Manufacturers

2.1 Global Propranolol Sales Market Share by Manufacturers (2017-2022)

2.2 Global Propranolol Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Propranolol Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Propranolol Manufacturing Sites, Area Served, Product Type

2.5 Propranolol Market Competitive Situation and Trends

2.5.1 Propranolol Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Propranolol Players Market Share by Revenue

2.5.3 Global Propranolol Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Propranolol Retrospective Market Scenario by Region

3.1 Global Propranolol Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Propranolol Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Propranolol Market Facts & Figures by Country

3.3.1 North America Propranolol Sales by Country

3.3.2 North America Propranolol Revenue by Country

3.3.3 United States

3.3.4 Canada

3.4 Europe Propranolol Market Facts & Figures by Country

3.4.1 Europe Propranolol Sales by Country

3.4.2 Europe Propranolol Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Propranolol Market Facts & Figures by Region

3.5.1 Asia Pacific Propranolol Sales by Region

3.5.2 Asia Pacific Propranolol Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 China Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.6 Latin America Propranolol Market Facts & Figures by Country

3.6.1 Latin America Propranolol Sales by Country

3.6.2 Latin America Propranolol Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.6.6 Colombia

3.7 Middle East and Africa Propranolol Market Facts & Figures by Country

3.7.1 Middle East and Africa Propranolol Sales by Country

3.7.2 Middle East and Africa Propranolol Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Propranolol Historic Market Analysis by Type

4.1 Global Propranolol Sales Market Share by Type (2017-2022)

4.2 Global Propranolol Revenue Market Share by Type (2017-2022)

4.3 Global Propranolol Price by Type (2017-2022)

5 Global Propranolol Historic Market Analysis by Application

5.1 Global Propranolol Sales Market Share by Application (2017-2022)

5.2 Global Propranolol Revenue Market Share by Application (2017-2022)

5.3 Global Propranolol Price by Application (2017-2022)

6 Key Companies Profiled

6.1 Apotex

6.1.1 Apotex Corporation Information

6.1.2 Apotex Description and Business Overview

6.1.3 Apotex Propranolol Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Apotex Propranolol Product Portfolio

6.1.5 Apotex Recent Developments/Updates

6.2 Teva

6.2.1 Teva Corporation Information

6.2.2 Teva Description and Business Overview

6.2.3 Teva Propranolol Sales, Revenue and Gross Margin (2017-2022)

6.2.4 Teva Propranolol Product Portfolio

6.2.5 Teva Recent Developments/Updates

6.3 Atnas Pharma

6.3.1 Atnas Pharma Corporation Information

6.3.2 Atnas Pharma Description and Business Overview

6.3.3 Atnas Pharma Propranolol Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Atnas Pharma Propranolol Product Portfolio

6.3.5 Atnas Pharma Recent Developments/Updates

6.4 AstraZeneca

6.4.1 AstraZeneca Corporation Information

6.4.2 AstraZeneca Description and Business Overview

6.4.3 AstraZeneca Propranolol Sales, Revenue and Gross Margin (2017-2022)

6.4.4 AstraZeneca Propranolol Product Portfolio

6.4.5 AstraZeneca Recent Developments/Updates

6.5 Mylan

6.5.1 Mylan Corporation Information

6.5.2 Mylan Description and Business Overview

6.5.3 Mylan Propranolol Sales, Revenue and Gross Margin (2017-2022)

6.5.4 Mylan Propranolol Product Portfolio

6.5.5 Mylan Recent Developments/Updates

6.6 Novartis

6.6.1 Novartis Corporation Information

6.6.2 Novartis Description and Business Overview

6.6.3 Novartis Propranolol Sales, Revenue and Gross Margin (2017-2022)

6.6.4 Novartis Propranolol Product Portfolio

6.6.5 Novartis Recent Developments/Updates

6.7 Sanofi

6.6.1 Sanofi Corporation Information

6.6.2 Sanofi Description and Business Overview

6.6.3 Sanofi Propranolol Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Sanofi Propranolol Product Portfolio

6.7.5 Sanofi Recent Developments/Updates

6.8 Yabang Pharma

6.8.1 Yabang Pharma Corporation Information

6.8.2 Yabang Pharma Description and Business Overview

6.8.3 Yabang Pharma Propranolol Sales, Revenue and Gross Margin (2017-2022)

6.8.4 Yabang Pharma Propranolol Product Portfolio

6.8.5 Yabang Pharma Recent Developments/Updates

6.9 Sawai Seiyaku

6.9.1 Sawai Seiyaku Corporation Information

6.9.2 Sawai Seiyaku Description and Business Overview

6.9.3 Sawai Seiyaku Propranolol Sales, Revenue and Gross Margin (2017-2022)

6.9.4 Sawai Seiyaku Propranolol Product Portfolio

6.9.5 Sawai Seiyaku Recent Developments/Updates

6.10 ABZ-Pharma

6.10.1 ABZ-Pharma Corporation Information

6.10.2 ABZ-Pharma Description and Business Overview

6.10.3 ABZ-Pharma Propranolol Sales, Revenue and Gross Margin (2017-2022)

6.10.4 ABZ-Pharma Propranolol Product Portfolio

6.10.5 ABZ-Pharma Recent Developments/Updates

6.11 Towa Yakuhin

6.11.1 Towa Yakuhin Corporation Information

6.11.2 Towa Yakuhin Propranolol Description and Business Overview

6.11.3 Towa Yakuhin Propranolol Sales, Revenue and Gross Margin (2017-2022)

6.11.4 Towa Yakuhin Propranolol Product Portfolio

6.11.5 Towa Yakuhin Recent Developments/Updates

6.12 Zydus Pharma

6.12.1 Zydus Pharma Corporation Information

6.12.2 Zydus Pharma Propranolol Description and Business Overview

6.12.3 Zydus Pharma Propranolol Sales, Revenue and Gross Margin (2017-2022)

6.12.4 Zydus Pharma Propranolol Product Portfolio

6.12.5 Zydus Pharma Recent Developments/Updates

6.13 Nichi-Iko Pharmaceutical

6.13.1 Nichi-Iko Pharmaceutical Corporation Information

6.13.2 Nichi-Iko Pharmaceutical Propranolol Description and Business Overview

6.13.3 Nichi-Iko Pharmaceutical Propranolol Sales, Revenue and Gross Margin (2017-2022)

6.13.4 Nichi-Iko Pharmaceutical Propranolol Product Portfolio

6.13.5 Nichi-Iko Pharmaceutical Recent Developments/Updates

6.14 Intas Pharma

6.14.1 Intas Pharma Corporation Information

6.14.2 Intas Pharma Propranolol Description and Business Overview

6.14.3 Intas Pharma Propranolol Sales, Revenue and Gross Margin (2017-2022)

6.14.4 Intas Pharma Propranolol Product Portfolio

6.14.5 Intas Pharma Recent Developments/Updates

6.15 IFET

6.15.1 IFET Corporation Information

6.15.2 IFET Propranolol Description and Business Overview

6.15.3 IFET Propranolol Sales, Revenue and Gross Margin (2017-2022)

6.15.4 IFET Propranolol Product Portfolio

6.15.5 IFET Recent Developments/Updates

6.16 Iqfarma

6.16.1 Iqfarma Corporation Information

6.16.2 Iqfarma Propranolol Description and Business Overview

6.16.3 Iqfarma Propranolol Sales, Revenue and Gross Margin (2017-2022)

6.16.4 Iqfarma Propranolol Product Portfolio

6.16.5 Iqfarma Recent Developments/Updates

6.17 Zentiva

6.17.1 Zentiva Corporation Information

6.17.2 Zentiva Propranolol Description and Business Overview

6.17.3 Zentiva Propranolol Sales, Revenue and Gross Margin (2017-2022)

6.17.4 Zentiva Propranolol Product Portfolio

6.17.5 Zentiva Recent Developments/Updates

7 Propranolol Manufacturing Cost Analysis

7.1 Propranolol Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Propranolol

7.4 Propranolol Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Propranolol Distributors List

8.3 Propranolol Customers

9 Propranolol Market Dynamics

9.1 Propranolol Industry Trends

9.2 Propranolol Market Drivers

9.3 Propranolol Market Challenges

9.4 Propranolol Market Restraints

10 Global Market Forecast

10.1 Propranolol Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Propranolol by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Propranolol by Type (2023-2028)

10.2 Propranolol Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Propranolol by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Propranolol by Application (2023-2028)

10.3 Propranolol Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Propranolol by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Propranolol by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample